Last reviewed · How we verify
Relapsing forms of multiple sclerosis
Approved treatments
- Vumerity · Biogen
Vumerity works by binding to the hydroxycarboxylic acid receptor 2, which helps to reduce inflammation in the central nervous system. - BRIUMVI · TG THERAPEUTICS, INC
- Vumerity · University of Nebraska
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Relapsing forms of multiple sclerosis patent landscape — cliff calendar, originator estates, attackable patents
- Relapsing forms of multiple sclerosis treatment landscape brief
- Relapsing forms of multiple sclerosis treatment updates RSS
Frequently asked questions about Relapsing forms of multiple sclerosis
What drugs treat Relapsing forms of multiple sclerosis?
Tracked treatments include Vumerity, BRIUMVI.
What is the treatment for Relapsing forms of multiple sclerosis?
Standard treatment for Relapsing forms of multiple sclerosis includes Vumerity, BRIUMVI. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Relapsing forms of multiple sclerosis patent cliff · Relapsing forms of multiple sclerosis CI report
- Treatment: Vumerity · Biogen
- Treatment: BRIUMVI · TG THERAPEUTICS, INC
- Treatment: Vumerity · University of Nebraska
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing